Haemophilia, 1351-8216

Journal

More filtering options
  1. 2019
  2. Joint comorbidities among Swedish carriers of haemophilia: A register-based cohort study over 22 years

    Mehdi Osooli, Donfield, S. M., Katarina Steen Carlsson, Baghaei, F., Holmström, M., Erik Berntorp & Jan Astermark, 2019 Aug 14, In : Haemophilia.

    Research output: Contribution to journalArticle

  3. Coagulation factor VIII is vital for increasing global coagulation after physical exercise

    Ljungkvist, M., Olofsson, H., Funding, E., Erik Berntorp & Eva Zetterberg, 2019, In : Haemophilia. 25, 2, p. e86-e93

    Research output: Contribution to journalArticle

  4. Evaluation of a standardized protocol for thrombin generation using the calibrated automated thrombogram: A Nordic study

    Ljungkvist, M., Strandberg, K., Erik Berntorp, Chaireti, R., Holme, P. A., Larsen, O. H., Lassila, R., Jouppila, A., Szanto, T. & Eva Zetterberg, 2019, In : Haemophilia. 25, 2, p. 334-342

    Research output: Contribution to journalArticle

  5. Moderate haemophilia in focus

    Erik Berntorp, 2019, In : Haemophilia. 25, 2, p. 187-188

    Research output: Contribution to journalDebate/Note/Editorial

  6. Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies

    Volkers, P., Hanschmann, K-M., Calvez, T., Chambost, H., Collins, P. W., Demiguel, V., Hart, D. P., Hay, C. R. M., Goudemand, J., Rolf Ljung, Palmer, B. P., Santagostino, E., van Hardeveld, E. M., van den Berg, M. & Keller-Stanislawski, B., 2019, In : Haemophilia. 25, 3, p. 398-407

    Research output: Contribution to journalArticle

  7. Sports participation and physical activity in adult Dutch and Swedish patients with severe haemophilia: A comparison between intermediate- and high-dose prophylaxis

    Versloot, O., Erik Berntorp, Petrini, P., Rolf Ljung, Jan Astermark, Holmström, M., de Kleijn, P. & Fischer, K., 2019, In : Haemophilia. 25, 2, p. 244-251

    Research output: Contribution to journalArticle

  8. 2018
  9. Fifth Åland Island conference on von Willebrand disease

    E. Berntorp, Ågren, A., Aledort, L., Blombäck, M., Cnossen, M. H., Croteau, S. E., von Depka, M., Federici, A. B., Goodeve, A., Goudemand, J., Mannucci, P. M., Mourik, M., Önundarson, P. T., Rodeghiero, F., Szántó, T. & Windyga, J., 2018 May 1, In : Haemophilia. 24, p. 5-19 15 p.

    Research output: Contribution to journalArticle

  10. Replacement therapy during surgery in von Willebrand disease needs personalization

    E. Berntorp, 2018 May 1, In : Haemophilia. 24, 3, p. 338-340 3 p.

    Research output: Contribution to journalDebate/Note/Editorial

  11. The role of the laboratory in diagnosis and management of inhibitory antibodies in haemophilia

    Strandberg, K. & J. Astermark, 2018 May 1, In : Haemophilia. 24, p. 9-14 6 p.

    Research output: Contribution to journalArticle

  12. Defining extended half-life rFVIII-A critical review of the evidence

    Mahlangu, J., Young, G., Hermans, C., Blanchette, V., E. Berntorp & Santagostino, E., 2018 May, In : Haemophilia. 24, 3, p. 348-358

    Research output: Contribution to journalArticle

  13. Pharmacokinetic modelling and validation of the half-life extension needed to reduce the burden of infusions compared with standard factor VIII

    Hermans, C., Mahlangu, J., Booth, J., Schütz, H., Santagostino, E., Young, G., Lee, H. Y., Steinitz-Trost, K. N., Blanchette, V. & E. Berntorp, 2018 May, In : Haemophilia. 24, 3, p. 376-384

    Research output: Contribution to journalArticle

  14. Immune tolerance induction: What have we learned over time?

    Brackmann, H. H., White, G. C., E. Berntorp, Andersen, T. & Escuriola-Ettingshausen, C., 2018 Apr 1, In : Haemophilia. 24, p. 3-14 12 p.

    Research output: Contribution to journalReview article

  15. Evaluation of prophylactic therapy in haemophilia with global coagulation tests

    E. Zetterberg, Brolin, K., Lindahl, R., Knobe, K. & E. Berntorp, 2018 Jan 1, In : Haemophilia. 24, 1, p. e10-e13

    Research output: Contribution to journalLetter

  16. 2017
  17. Preference-based valuation of treatment attributes in haemophilia A using web survey

    K. Steen Carlsson, Andersson, E. & E. Berntorp, 2017 Nov 1, In : Haemophilia. 23, 6, p. 894-903 10 p.

    Research output: Contribution to journalArticle

  18. The impact of clinical practice on the outcome of central venous access devices in children with haemophilia

    Khair, K., Ranta, S., Thomas, A. & Lindvall, K., 2017 Jul 1, In : Haemophilia. 23, 4, p. e276-e281

    Research output: Contribution to journalArticle

  19. Comparative burden of arthropathy in mild haemophilia: a register-based study in Sweden

    M Osooli, Lövdahl, S., K Steen Carlsson, Knobe, K., Baghaei, F., Holmström, M., J Astermark & E Berntorp, 2017 Mar, In : Haemophilia. 23, 2, p. e79-e86

    Research output: Contribution to journalArticle

  20. European retrospective study of real-life haemophilia treatment

    E. Berntorp, Dolan, G., Hay, C., Linari, S., Santagostino, E., Tosetto, A., Castaman, G., Álvarez-Román, M., Parra Lopez, R., Oldenburg, J., Albert, T., Scholz, U., Holmström, M., Schved, J. F., Trossaërt, M., Hermans, C., Boban, A., Ludlam, C. & Lethagen, S., 2017 Jan, In : Haemophilia. 23, 1, p. 105-114

    Research output: Contribution to journalArticle

  21. Anti-factor VIII antibodies in brothers with haemophilia A share similar characteristics

    Kahle, J., Orlowski, A., Stichel, D., Healey, J. F., Parker, E. T., Donfield, S. M., J. Astermark, E. Berntorp, Lollar, P., Schwabe, D. & Königs, C., 2017, In : Haemophilia. 23, 2, p. 292-299

    Research output: Contribution to journalArticle

  22. Discrepancies between the one-stage clotting assay and the chromogenic assay in haemophilia B

    K. Kihlberg, Strandberg, K., Rosén, S., R. Ljung & J. Astermark, 2017, In : Haemophilia. 23, 4, p. 620-627

    Research output: Contribution to journalArticle

  23. Low agreement between fresh and frozen-thawed platelet-rich plasma in the calibrated automated thrombogram assay

    Ljungkvist, M., Lövdahl, S., E. Zetterberg & E. Berntorp, 2017, In : Haemophilia. 23, 3, p. e214-e218

    Research output: Contribution to journalArticle

  24. Measuring FVIII activity of glycopegylated recombinant factor VIII, N8-GP, with commercially available one-stage clotting and chromogenic assay kits: A two-centre study

    A. Hillarp, Bowyer, A. E., Ezban, M., Persson, P. & Kitchen, S., 2017, In : Haemophilia. 23, 3, p. 458-465

    Research output: Contribution to journalArticle

  25. Plasma products do not solve the inhibitor problem

    van den Berg, H. M., Pipe, S. & R. Ljung, 2017, In : Haemophilia. 23, 3, p. 346-347

    Research output: Contribution to journalDebate/Note/Editorial

  26. The association between health utility and joint status among people with severe haemophilia A: findings from the KAPPA register

    M Osooli, K Steen Carlsson, Baghaei, F., Holmström, M., Rauchensteiner, S., Holme, P. A., Hvitfeldt, L., J Astermark & E Berntorp, 2017, In : Haemophilia. 23, 3, p. e180-e187

    Research output: Contribution to journalArticle

  27. 2016
  28. Inhibitor development in previously untreated patients with severe haemophilia A: a nationwide multicentre study in Finland

    Vepsäläinen, K., Lassila, R., Arola, M., Huttunen, P., Koskinen, S., R. Ljung, Lähteenmäki, P., Möttönen, M. & Riikonen, P., 2016 Sep 1, In : Haemophilia. 22, 5, p. 721-729 9 p.

    Research output: Contribution to journalArticle

  29. Potential biomarkers of haemophilic arthropathy: correlations with compatible additive magnetic resonance imaging scores

    Oldenburg, J., Zimmermann, R., Katsarou, O., Zanon, E., Kellermann, E., B. Lundin & Ellinghaus, P., 2016 Sep 1, In : Haemophilia. 22, 5, p. 760-764 5 p.

    Research output: Contribution to journalArticle

  30. Haemophilia treatment in 2030

    E. Berntorp, 2016 Jul 1, In : Haemophilia. 22, S5, p. 15-19 5 p.

    Research output: Contribution to journalArticle

  31. Phenotype and genotype comparisons in carriers of haemophilia A

    Olsson, A., R Ljung, Hellgren, M., E Berntorp & Baghaei, F., 2016 May, In : Haemophilia. 22, 3, p. 235–237

    Research output: Contribution to journalArticle

  32. Hypertension, haematuria and renal functioning in haemophilia - a cross-sectional study in Europe

    Holme, P. A., Combescure, C., Tait, R. C., E. Berntorp, Rauchensteiner, S. & de Moerloose, P., 2016 Mar 1, In : Haemophilia. 22, 2, p. 248-255 8 p.

    Research output: Contribution to journalArticle

  33. Association of peak factor VIII levels and area under the curve with bleeding in patients with haemophilia A on every third day pharmacokinetic-guided prophylaxis.

    Valentino, L. A., Pipe, S. W., Collins, P. W., Blanchette, V. S., Erik Berntorp, Fischer, K., Ewenstein, B. M., Oh, M. & Spotts, G., 2016, In : Haemophilia. 22, 4, p. 514-20

    Research output: Contribution to journalArticle

  34. BAY 81-8973 safety and efficacy for prophylaxis and treatment of bleeds in previously treated children with severe haemophilia A: results of the LEOPOLD Kids Trial.

    Rolf Ljung, Kenet, G., Mancuso, M. E., Kaleva, V., Rusen, L., Tseneklidou-Stoeter, D., Michaels, L. A., Shah, A., Hong, W. & Maas Enriquez, M., 2016, In : Haemophilia. 22, 3, p. 354-360

    Research output: Contribution to journalArticle

  35. Dosing regimens, FVIII levels and estimated haemostatic protection with special focus on rFVIIIFc.

    Erik Berntorp, Negrier, C., Gozzi, P., Blaas, P-M. & Lethagen, S., 2016, In : Haemophilia.

    Research output: Contribution to journalArticle

  36. Evaluating outcome of prophylaxis in haemophilia: objective and self-reported instruments should be combined.

    Fischer, K., Nijdam, A., Holmström, M., Petrini, P., Rolf Ljung, van der Schouw, Y. T. & Berntorp, E., 2016, In : Haemophilia.

    Research output: Contribution to journalArticle

  37. 2015
  38. Acute effects of exercise on specific and global coagulation parameters in severe haemophilia A.

    Olofsson, H. E., Lövdahl, S., Ola Thorsson, Erik Berntorp & Eva Zetterberg, 2015, In : Haemophilia. 21, 5, p. E416-E419

    Research output: Contribution to journalLetter

  39. Association between bleeding tendency and health-related quality of life in carriers of moderate and severe haemophilia.

    Olsson, A., Hellgren, M., Erik Berntorp & Baghaei, F., 2015, In : Haemophilia. 21, 6, p. 742-746

    Research output: Contribution to journalArticle

  40. Bleeding phenotype in carriers of haemophilia A does not correlate with thrombin generation

    Olsson, A., Hellgren, M., Erik Berntorp, Holmstrom, M. & Baghaei, F., 2015, In : Haemophilia. 21, 1, p. E111-E113

    Research output: Contribution to journalLetter

  41. Comparison of several von Willebrand factor (VWF) activity assays for monitoring patients undergoing treatment with VWF/FVIII concentrates: improved performance with a new modified automated method.

    Andreas Hillarp, Friedman, K. D., Adcock-Funk, D., Tiefenbacher, S., Nichols, W. L., Chen, D., Stadler, M. & Schwartz, B. A., 2015, In : Haemophilia. 21, 6, p. 837-845

    Research output: Contribution to journalArticle

  42. Controlled, cross-sectional MRI evaluation of joint status in severe haemophilia A patients treated with prophylaxis vs. on demand

    Oldenburg, J., Zimmermann, R., Katsarou, O., Theodossiades, G., Zanon, E., Niemann, B., Kellermann, E. & Björn Lundin, 2015, In : Haemophilia. 21, 2, p. 171-179

    Research output: Contribution to journalArticle

  43. How to achieve full prophylaxis in young boys with severe haemophilia A: different regimens and their effect on early bleeding and venous access

    Nijdam, A., Kurnik, K., Liesner, R., Rolf Ljung, Nolan, B., Petrini, P. & Fischer, K., 2015, In : Haemophilia. 21, 4, p. 444-450

    Research output: Contribution to journalArticle

  44. Mutation analysis of Swedish haemophilia B families - high frequency of unique mutations.

    Annika Mårtensson, Letelier, A., Halldén, C. & Rolf Ljung, 2015, In : Haemophilia.

    Research output: Contribution to journalArticle

  45. The natural history of occult or angiodysplastic gastrointestinal bleeding in von Willebrand disease

    Makris, M., Federici, A. B., Mannucci, P. M., Bolton-Maggs, P. H. B., Yee, T. T., Abshire, T. & Erik Berntorp, 2015, In : Haemophilia. 21, 3, p. 338-342

    Research output: Contribution to journalArticle

  46. 2014
  47. Similar bleeding phenotype in young children with haemophilia A or B: A cohort study

    Rodin Study group, 2014 Nov 1, In : Haemophilia. 20, 6, p. 747-755 9 p.

    Research output: Contribution to journalArticle

  48. A longitudinal study of family structure in Swedish persons with haemophilia.

    Lövdahl, S., Henriksson, K. M., Baghaei, F., Holmström, M., Erik Berntorp & Jan Astermark, 2014, In : Haemophilia. 20, 4, p. 493-499

    Research output: Contribution to journalArticle

  49. Laboratory aspects of von Willebrand disease: test repertoire and options for activity assays and genetic analysis

    Castaman, G., Andreas Hillarp & Goodeve, A., 2014, In : Haemophilia. 20, p. 65-70

    Research output: Contribution to journalReview article

  50. Managing Haemophilia for Life: 4th Haemophilia Global Summit

    Jan Astermark, Dolan, G., Hilberg, T., Jimenez-Yuste, V., Laffan, M., Lassila, R., Lobet, S., Martinoli, C. & Perno, C. -F., 2014, In : Haemophilia. 20, p. 1-20

    Research output: Contribution to journalReview article

  51. Pharmacokinetics, phenotype and product choice in haemophilia B: how to strike a balance?

    Erik Berntorp, Dolan, G., Hermans, C., Laffan, M., Santagostino, E. & Tiede, A., 2014, In : Haemophilia. 20, p. 1-11

    Research output: Contribution to journalArticle

Previous 1 2 3 4 5 6 Next